- Home
- MGX vs AFJK Comparison
MGX vs AFJK Comparison
Compare MGX & AFJK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGX
- AFJK
- Stock Information
- Founded
- MGX 2018
- AFJK 2023
- Country
- MGX United States
- AFJK United States
- Employees
- MGX N/A
- AFJK N/A
- Industry
- MGX
- AFJK
- Sector
- MGX
- AFJK
- Exchange
- MGX NYSE
- AFJK NYSE
- Market Cap
- MGX 62.1M
- AFJK 68.3M
- IPO Year
- MGX 2024
- AFJK 2023
- Fundamental
- Price
- MGX $1.52
- AFJK $11.15
- Analyst Decision
- MGX Strong Buy
- AFJK
- Analyst Count
- MGX 4
- AFJK 0
- Target Price
- MGX $13.00
- AFJK N/A
- AVG Volume (30 Days)
- MGX 665.7K
- AFJK 1.8K
- Earning Date
- MGX 08-13-2025
- AFJK 01-01-0001
- Dividend Yield
- MGX N/A
- AFJK N/A
- EPS Growth
- MGX N/A
- AFJK N/A
- EPS
- MGX N/A
- AFJK 0.23
- Revenue
- MGX $45,263,000.00
- AFJK N/A
- Revenue This Year
- MGX N/A
- AFJK N/A
- Revenue Next Year
- MGX $11.75
- AFJK N/A
- P/E Ratio
- MGX N/A
- AFJK $48.34
- Revenue Growth
- MGX N/A
- AFJK N/A
- 52 Week Low
- MGX $1.23
- AFJK $10.24
- 52 Week High
- MGX $5.50
- AFJK $11.20
- Technical
- Relative Strength Index (RSI)
- MGX 47.41
- AFJK N/A
- Support Level
- MGX $1.46
- AFJK N/A
- Resistance Level
- MGX $1.66
- AFJK N/A
- Average True Range (ATR)
- MGX 0.13
- AFJK 0.00
- MACD
- MGX 0.00
- AFJK 0.00
- Stochastic Oscillator
- MGX 46.30
- AFJK 0.00
About MGX METAGENOMI INC
Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. The genome editing toolbox includes systems for making small edits such as programmable nucleases, base editors, small RNA-mediated integration systems (RIGS), as well as large gene integration systems including large template RIGS and CRISPR-associated transposases (CASTs). The company is focused on its vivo gene editing for its wholly-owned pipeline while pursuing technology out licensing for ex vivo cell therapy. Its pipeline includes product candidates aimed at addressing disorders like Hemophilia A (through MGX-001), Refractory Hypertension, Cardiovascular diseases, and Wilson's disease, among others.
About AFJK AIMEI HEALTH TECHNOLOGY CO LTD
Aimei Health Technology Co Ltd is a blank check company.